用于DDU和APSD的IVIVC测试系统
Two factors have been identified as being critical to improving the clinical relevance of DDU testing and APSD measurement: realistic breathing profiles and realistic throat and nasal models.
System for Improved In Vitro-In Vivo Correlations (IVIVCs) of Inhaled Drug Products
播放视频相关新闻与资源
Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over…
了解详情Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade…
了解详情New e-Training service from Copley for pharmaceutical testing
14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro…
了解详情Improving clinical realism: Upgraded IVIVC testing systems from Copley Scientific
29th June 2018; Nottingham, UK: New products from Copley Scientific enhance its offering for improving IVIVCs for orally inhaled and nasal drug products (OINDPs)….
了解详情New research demonstrates the ability of the Child Alberta Idealised Throat to deliver better IVIVRs
28 May 2015; Nottingham, UK: New experimental studies using the Child Alberta Idealised Throat (C-AIT) from Copley Scientific confirm that it provides data more…
了解详情Copley Scientific introduces improved test set-up for more representative inhaled product testing
5 August 2014; Nottingham, UK: The desire to gain a better understanding of how inhaled products perform in patients has highlighted the importance and…
了解详情Introducing the new Alberta Idealized Throats from Copley Scientific – closer IVIVC in inhaled product testing
1 December 2010; Nottingham, UK: The Alberta Idealized Throat is a new product from Copley Scientific designed to improve in vivo/in vitro correlation (IVIVC)…
了解详情Inhalation Article: April 2019
The regulatory landscape for OINDPs – the biggest shake-up in a generation?
了解详情Drug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
了解详情White Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
了解详情PMPS Article (Samedan): February 2018
Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally…
了解详情